| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 19 |
| 1 | DEXAMETHASONE 1.5 MG | 19 |
| 2 | BORTEZOMIB | 15 |
| 3 | OLAPARIB | 14 |
| 4 | CARBOPLATIN | 12 |
| 5 | CYCLOPHOSPHAMIDE | 11 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 11 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 11 |
| 8 | PACLITAXEL | 11 |
| 9 | PACLITAXEL (AIBUMIN-BOUND) | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BREXUCABTAGENE AUTOLEUCEL | 4 | 0.0019 |
| 1 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 2 | 0.0008 |
| 2 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| 3 | TALQUETAMAB-TGVS | 1 | 0.0007 |
| 4 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| 5 | OLAPARIB | 14 | 0.0007 |
| 6 | TALAZOPARIB | 1 | 0.0005 |
| 7 | MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN | 1 | 0.0005 |
| 8 | ZINC OXIDE OINTMENT | 1 | 0.0005 |
| 9 | ZINC OXIDE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 31 |
| 1 | Platinum-based Drug [EPC] | 16 |
| 2 | Proteasome Inhibitor [EPC] | 15 |
| 3 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 14 |
| 4 | Alkylating Drug [EPC] | 11 |
| 5 | Microtubule Inhibitor [EPC] | 11 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 9 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 9 |
| 8 | Thalidomide Analog [EPC] | 8 |
| 9 | Kinase Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 2 | 0.0008 |
| 1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 14 | 0.0007 |
| 2 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 3 | Proteasome Inhibitor [EPC] | 15 | 0.0001 |
| 4 | Microtubule Inhibitor [EPC] | 11 | 0.0001 |
| 5 | Topoisomerase Inhibitor [EPC] | 5 | 0.0001 |
| 6 | BCL-2 Inhibitor [EPC] | 4 | 0.0001 |
| 7 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Platinum-based Drug [EPC] | 16 | 0.0001 |
| 9 | Alkylating Drug [EPC] | 11 | 0.0000 |